185 related articles for article (PubMed ID: 22142393)
1. The effect of pimecrolimus on expression of genes associated with skin barrier dysfunction in atopic dermatitis skin lesions.
Grzanka A; Zebracka-Gala J; Rachowska R; Bozek A; Kowalska M; Jarzab J
Exp Dermatol; 2012 Mar; 21(3):184-8. PubMed ID: 22142393
[TBL] [Abstract][Full Text] [Related]
2. Locus 1q21 Gene expression changes in atopic dermatitis skin lesions: deregulation of small proline-rich region 1A.
Jarzab J; Filipowska B; Zebracka J; Kowalska M; Bozek A; Rachowska R; Gubala E; Grzanka A; Hadas E; Jarzab B
Int Arch Allergy Immunol; 2010; 151(1):28-37. PubMed ID: 19672094
[TBL] [Abstract][Full Text] [Related]
3. Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis.
Jensen JM; Scherer A; Wanke C; Bräutigam M; Bongiovanni S; Letzkus M; Staedtler F; Kehren J; Zuehlsdorf M; Schwarz T; Weichenthal M; Fölster-Holst R; Proksch E
Allergy; 2012 Mar; 67(3):413-23. PubMed ID: 22142306
[TBL] [Abstract][Full Text] [Related]
4. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial.
Jensen JM; Weppner M; Dähnhardt-Pfeiffer S; Neumann C; Bräutigam M; Schwarz T; Fölster-Holst R; Proksch E
Acta Derm Venereol; 2013 Sep; 93(5):515-9. PubMed ID: 23571785
[TBL] [Abstract][Full Text] [Related]
5. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
Frankel A; Sohn A; Patel RV; Lebwohl M
J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
[TBL] [Abstract][Full Text] [Related]
6. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis.
Aschoff R; Schwanebeck U; Bräutigam M; Meurer M
Exp Dermatol; 2009 Jan; 18(1):24-9. PubMed ID: 18637133
[TBL] [Abstract][Full Text] [Related]
7. Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions.
Simon D; Lindberg RL; Kozlowski E; Braathen LR; Simon HU
Exp Dermatol; 2006 Jun; 15(6):441-6. PubMed ID: 16689860
[TBL] [Abstract][Full Text] [Related]
8. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
9. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
Jensen JM; Pfeiffer S; Witt M; Bräutigam M; Neumann C; Weichenthal M; Schwarz T; Fölster-Holst R; Proksch E
J Allergy Clin Immunol; 2009 May; 123(5):1124-33. PubMed ID: 19410693
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
11. Gene (mRNA) expression in canine atopic dermatitis: microarray analysis.
Merryman-Simpson AE; Wood SH; Fretwell N; Jones PG; McLaren WM; McEwan NA; Clements DN; Carter SD; Ollier WE; Nuttall T
Vet Dermatol; 2008 Apr; 19(2):59-66. PubMed ID: 18336422
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
13. Alterations of keratins, involucrin and filaggrin gene expression in canine atopic dermatitis.
Theerawatanasirikul S; Sailasuta A; Thanawongnuwech R; Suriyaphol G
Res Vet Sci; 2012 Dec; 93(3):1287-92. PubMed ID: 22784629
[TBL] [Abstract][Full Text] [Related]
14. [Tacrolimus and pimecrolimus ointments in the treatment of atopic eczema].
Reitamo S; Remitz A
Duodecim; 2003; 119(9):825-7. PubMed ID: 12815980
[No Abstract] [Full Text] [Related]
15. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
[TBL] [Abstract][Full Text] [Related]
16. Pimecrolimus 1% cream for the treatment of atopic dermatitis.
Wolff K
Skin Therapy Lett; 2005 Oct; 10(8):1-6. PubMed ID: 16292456
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography.
Aschoff R; Schmitt J; Knuschke P; Koch E; Bräutigam M; Meurer M
Exp Dermatol; 2011 Oct; 20(10):832-6. PubMed ID: 21771098
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
Ho VC; Gupta A; Kaufmann R; Todd G; Vanaclocha F; Takaoka R; Fölster-Holst R; Potter P; Marshall K; Thurston M; Bush C; Cherill R
J Pediatr; 2003 Feb; 142(2):155-62. PubMed ID: 12584537
[TBL] [Abstract][Full Text] [Related]
19. Expression of adhesion molecules in atopic dermatitis is reduced by tacrolimus, but not by hydrocortisone butyrate: a randomized immunohistochemical study.
Caproni M; Torchia D; Antiga E; Volpi W; Fabbri P
Clin Exp Dermatol; 2006 Nov; 31(6):813-7. PubMed ID: 17040264
[TBL] [Abstract][Full Text] [Related]
20. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
